These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3267306)

  • 1. Comparison of in vitro cloning assays for drug sensitivity testing of human brain tumours.
    Berens ME; Giblin JR; Dougherty DV; Hoifodt HK; Tveit K; Rosenblum ML
    Br J Neurosurg; 1988; 2(2):227-34. PubMed ID: 3267306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.
    Da Silva VF; Raaphorst GP; Goyal R; Feeley M
    J Neurosurg; 1987 Dec; 67(6):885-8. PubMed ID: 3681426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay.
    Ali-Osman F; Giblin J; Dougherty D; Rosenblum ML
    Cancer Res; 1987 Jul; 47(14):3718-24. PubMed ID: 2954633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum.
    Schold SC; Rawlings CE; Bigner SH; Bigner DD
    Neurosurgery; 1983 Jun; 12(6):672-7. PubMed ID: 6683794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.
    Paoletti P; Butti G; Knerich R; Gaetani P; Assietti R
    Acta Neurochir (Wien); 1990; 103(1-2):35-46. PubMed ID: 2360465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pharmacologic doses of zinc on the therapeutic index of brain tumor chemotherapy with carmustine.
    Roosen N; Doz F; Yeomans KL; Dougherty DV; Rosenblum ML
    Cancer Chemother Pharmacol; 1994; 34(5):385-92. PubMed ID: 7520843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of human tumor cell chemosensitivity using the sister chromatid exchange assay.
    Deen DF; Kendall LE; Marton LJ; Tofilon PJ
    Cancer Res; 1986 Apr; 46(4 Pt 1):1599-602. PubMed ID: 3948148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
    Tonn JC; Schönmayr R; Kraemer HP
    J Neurooncol; 1990 Feb; 8(1):41-5. PubMed ID: 2319289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro drug sensitivity testing in human gliomas.
    Kimmel DW; Shapiro JR; Shapiro WR
    J Neurosurg; 1987 Feb; 66(2):161-71. PubMed ID: 3543252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
    Aida T; Bodell WJ
    No To Shinkei; 1987 Mar; 39(3):235-41. PubMed ID: 3472531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of the cytotoxicity of the morpholino anthracycline MX2 against glioma cells in vitro.
    Park SJ; Kaye AH; Hill JS
    J Clin Neurosci; 2000 Jan; 7(1):42-7. PubMed ID: 10847650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
    Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma.
    Schold SC; Herndon JE; Burger PC; Halperin EC; Vick NA; Cairncross JG; Macdonald DR; Dropcho EJ; Morawetz R; Bigner DD
    J Clin Oncol; 1993 Jan; 11(1):77-83. PubMed ID: 8418246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitivity of malignant human brain tumors. Preliminary results.
    Bogdahn U
    J Neurooncol; 1983; 1(2):149-66. PubMed ID: 6088712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
    Slagel DE; Feola J; Houchens DP; Ovejera AA
    Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
    Zhang RX; Dougherty DV; Rosenblum ML
    Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells.
    Khoshyomn S; Nathan D; Manske GC; Osler TM; Penar PL
    J Neurooncol; 2002 May; 57(3):193-200. PubMed ID: 12125982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential antiglioma activity of 9-hydroxy-2-N-methylellipticine as determined by pharmacological and human tumor clonogenic cell studies.
    Ali-Osman F; Rosenblum ML; Giannini DD; Levin VA
    Cancer Res; 1985 Jul; 45(7):2988-92. PubMed ID: 4005838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
    Tofilon PJ; Basic I; Milas L
    Cancer Res; 1985 May; 45(5):2025-30. PubMed ID: 4039220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
    Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schachenmayr W; Schönmayr R
    J Neurooncol; 1992 May; 13(1):13-24. PubMed ID: 1613536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.